OpenLB
Open Library of Bioscience
Advanced Search
Journal of the Saudi Heart Association
2022;34 (3): 182-211.

Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes.

Owayed AlShammeri, Shukri Al Saif, Halia Al Shehri, Mirvat Alasng, Fatema Qaddoura, Mohammad Al Shehri, Yosra Turkistani, Adel Tash, Walid Alharbi, Fahad Al Qahtani, Rafael Diaz, Wael Mahaimeed, Waleed Al Habeeb, Khalid Alfaraidy
Author Information
  1. Owayed AlShammeri: Dr. Sulaiman Al-Habib Hospital, Riyadh, Saudi Arabia.
  2. Shukri Al Saif: Saud Albabtain Cardiac Center, Dammam, Saudi Arabia.
  3. Halia Al Shehri: King Salman Heart Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
  4. Mirvat Alasng: Cardiac Center, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
  5. Fatema Qaddoura: Dr. Suliman AL-Habib Hospital, Al-khobar, Saudi Arabia.
  6. Mohammad Al Shehri: Armed Forces Hospitals Southern Region, Saudi Arabia.
  7. Yosra Turkistani: Umm AlQura University, Makkah, Saudi Arabia.
  8. Adel Tash: National Heart Center, Saudi Health Council, Saudi Arabia.
  9. Walid Alharbi: King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia.
  10. Fahad Al Qahtani: King Salman Heart Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
  11. Rafael Diaz: ECLA (Estudios Cl��nicos Latino Am��rica), Instituto Cardiovascular de Rosario, Rosario, Argentina.
  12. Wael Mahaimeed: Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
  13. Waleed Al Habeeb: Saudi Heart Association, Department of Cardiac Sciences, King Saud University Riyadh, Saudi Arabia.
  14. Khalid Alfaraidy: King Fahad Military Medical Complex, Dhahran, Saudi Arabia.
PMID: 36578770 DOI: 10.37616/2212-5043.1320

Abstract

Background: The prevalence of both chronic coronary syndrome (CCS) and its risk factors is alarming in Saudi Arabia and only a minority of patients achieve optimal medical management. Context-specific CCS guidelines outlining best clinical practices are therefore needed to address local gaps and challenges.
Consensus panel: A panel of experts representing the Saudi Heart Association (SHA) reviewed existing evidence and formulated guidance relevant to local clinical practice considering the characteristics of the Saudi population, the Saudi healthcare system, its resources and medical expertise. They were reviewed by external experts to ensure scientific and medical accuracy.
Consensus findings: Recommendations are provided on the clinical assessment and management of CCS, along with supporting evidence. Risk reduction through non-pharmacological therapy (lifestyle modifications) remains at the core of CCS management. Great emphasis should be placed on the use of available pharmacological options (anti-anginal therapy and event prevention) only as appropriate and necessary. Lifestyle counseling and pharmacological strategy must be optimized before considering revascularization, unless otherwise indicated. Revascularization strategies should be carefully considered by the Heart Team to ensure the appropriate choice is made in accordance to current guidelines and patient preference.
Conclusion: Conscientious, multidisciplinary, and personalized clinical management is necessary to navigate the complex landscape of CCS in Saudi Arabia considering its population and resource differences. The reconciliation of international evidence and local characteristics is critical for the improvement of healthcare outcomes among CCS patients in Saudi Arabia.

Keywords

Chronic coronary syndrome Guidelines Saudi Arabia

References

  1. J Diabetes Res. 2022 Jan 25;2022:8183487 [PMID: 35127952]
  2. BMC Public Health. 2020 Aug 8;20(1):1213 [PMID: 32770968]
  3. Circ Cardiovasc Interv. 2019 Sep;12(9):e008007 [PMID: 31495220]
  4. J Am Coll Cardiol. 2009 Jul 7;54(2):150-6 [PMID: 19573732]
  5. J Am Coll Cardiol. 2022 May 3;79(17):1690-1700 [PMID: 35483757]
  6. Brain Sci. 2020 May 22;10(5): [PMID: 32455944]
  7. Eur J Prev Cardiol. 2015 Jul;22(7):837-48 [PMID: 24776376]
  8. Circulation. 1989 Jul;80(1):87-98 [PMID: 2661056]
  9. J Saudi Heart Assoc. 2009 Jul;21(3):169-76 [PMID: 23960568]
  10. N Engl J Med. 2019 Oct 3;381(14):1309-1320 [PMID: 31475798]
  11. Heart Lung Circ. 2019 May;28(5):719-726 [PMID: 29581037]
  12. Nicotine Tob Res. 2018 Jan 5;20(2):173-182 [PMID: 28177498]
  13. J Nucl Med. 2006 Jul;47(7):1107-18 [PMID: 16818945]
  14. Circulation. 1989 Nov;80(5):1328-37 [PMID: 2805269]
  15. Am J Cardiol. 2004 Sep 1;94(5):559-63 [PMID: 15342283]
  16. Cardiol Rev. 2022 Sep-Oct 01;30(5):263-266 [PMID: 34001687]
  17. Rev Cardiovasc Med. 2022 Jan 17;23(1):26 [PMID: 35092218]
  18. J Am Coll Cardiol. 2018 Mar 13;71(10):1094-1101 [PMID: 29519349]
  19. Circulation. 2010 Feb 16;121(6):750-8 [PMID: 20124123]
  20. J Am Coll Cardiol. 2019 Mar 5;73(8):964-976 [PMID: 30819365]
  21. Am Heart J. 2008 Aug;156(2):292-300 [PMID: 18657659]
  22. Heart Lung Circ. 2015 Feb;24(2):149-57 [PMID: 25306500]
  23. Am J Cardiol. 2014 Jun 15;113(12):1933-40 [PMID: 24793668]
  24. Cardiovasc Res. 2021 Dec 17;117(14):2705-2729 [PMID: 34528075]
  25. N Engl J Med. 2012 Dec 20;367(25):2375-84 [PMID: 23121323]
  26. J Am Coll Cardiol. 1986 Apr;7(4):775-89 [PMID: 3485669]
  27. J Clin Med. 2021 Apr 15;10(8): [PMID: 33920796]
  28. JAMA. 2022 Sep 6;328(9):887-889 [PMID: 35867050]
  29. Eur J Prev Cardiol. 2016 Sep;23(13):1401-12 [PMID: 27222385]
  30. J Nucl Cardiol. 2000 Sep-Oct;7(5):432-8 [PMID: 11083191]
  31. JAMA. 2009 Feb 4;301(5):500-7 [PMID: 19190314]
  32. Lancet. 2015 Jun 13;385(9985):2383-91 [PMID: 25788230]
  33. Cardiovasc Drugs Ther. 2016 Aug;30(4):419-426 [PMID: 27638354]
  34. JAMA. 2004 Jan 14;291(2):210-5 [PMID: 14722147]
  35. Medicine (Baltimore). 2016 Jun;95(26):e4059 [PMID: 27368043]
  36. Med Sci Monit. 2018 Dec 17;24:9166-9176 [PMID: 30557296]
  37. Circulation. 2017 Mar 14;135(11):1075-1092 [PMID: 28289007]
  38. Circulation. 1996 Sep 1;94(5):1175-92 [PMID: 8790070]
  39. Circulation. 2021 Sep 28;144(13):1024-1038 [PMID: 34496632]
  40. Circ Cardiovasc Imaging. 2008 Nov;1(3):257-69; discussion 269 [PMID: 19808550]
  41. Emerg Med Clin North Am. 2016 Aug;34(3):523-42 [PMID: 27475013]
  42. Open Access J Sports Med. 2018 Jan 26;9:1-17 [PMID: 29416382]
  43. J Saudi Heart Assoc. 2011 Oct;23(4):233-9 [PMID: 23960654]
  44. Am J Cardiol. 1970 Sep;26(3):241-7 [PMID: 5505449]
  45. N Engl J Med. 2018 Sep 06;379(10):924-933 [PMID: 30145934]
  46. Circ Cardiovasc Imaging. 2009 Jan;2(1):16-23 [PMID: 19808560]
  47. Heart. 2022 Feb;108(3):194-202 [PMID: 34686567]
  48. Tob Prev Cessat. 2021 Nov 22;7:69 [PMID: 34877438]
  49. J Am Coll Cardiol. 2018 Nov 6;72(19):2297-2305 [PMID: 30384885]
  50. JAMA Cardiol. 2017 Apr 1;2(4):400-408 [PMID: 28199464]
  51. Lancet. 2017 Nov 4;390(10107):2037-2049 [PMID: 28864331]
  52. Eur Heart J. 2019 May 7;40(18):1426-1435 [PMID: 30561616]
  53. EClinicalMedicine. 2022 Nov;53:101619 [PMID: 35971425]
  54. PLoS One. 2014 Aug 04;9(8):e102830 [PMID: 25090638]
  55. JACC Cardiovasc Imaging. 2009 Jul;2(7):916-8 [PMID: 19608145]
  56. Am J Cardiol. 2015 Nov 1;116(9):1469-78 [PMID: 26347004]
  57. Eur Heart J. 2014 Jul;35(26):1760-8 [PMID: 24616336]
  58. N Engl J Med. 2007 Nov 29;357(22):2277-84 [PMID: 18046031]
  59. Atherosclerosis. 2012 Feb;220(2):557-62 [PMID: 22189201]
  60. Eur Heart J. 2007 Dec;28(24):3042-50 [PMID: 17981829]
  61. Orv Hetil. 2021 Jul 18;162(29):1167-1171 [PMID: 34274921]
  62. J Nucl Med. 1994 Oct;35(10):1586-92 [PMID: 7931654]
  63. Nat Rev Cardiol. 2018 Feb;15(2):120-132 [PMID: 28880025]
  64. J Am Coll Cardiol. 2008 Mar 18;51(11):1127-47 [PMID: 18342240]
  65. J Am Coll Cardiol. 2019 Oct 1;74(13):1645-1654 [PMID: 31558246]
  66. N Engl J Med. 2003 Aug 7;349(6):523-34 [PMID: 12904517]
  67. Am J Roentgenol Radium Ther Nucl Med. 1959 May;81(5):772-7 [PMID: 13650017]
  68. Clin Ther. 2016 Feb;38(2):387-95 [PMID: 26839043]
  69. Int J Epidemiol. 2017 Jun 1;46(3):1029-1056 [PMID: 28338764]
  70. JAMA. 2005 Jan 26;293(4):477-84 [PMID: 15671433]
  71. Circulation. 2020 Sep;142(9):841-857 [PMID: 32794407]
  72. Am Heart J. 1991 Dec;122(6):1617-28 [PMID: 1957757]
  73. Eur J Prev Cardiol. 2014 Apr;21(4):400-10 [PMID: 23125402]
  74. JAMA Cardiol. 2020 Jul 1;5(7):773-786 [PMID: 32227128]
  75. Ther Adv Chronic Dis. 2022 Jan 17;13:20406223211056713 [PMID: 35070247]
  76. Cochrane Database Syst Rev. 2018 May 31;5:CD000146 [PMID: 29852054]
  77. Circ Cardiovasc Interv. 2020 Nov;13(11):e009654 [PMID: 33138626]
  78. J Am Coll Cardiol. 2017 Apr 11;69(14):1761-1770 [PMID: 28385304]
  79. Cureus. 2020 Nov 23;12(11):e11649 [PMID: 33376660]
  80. Eur Heart J. 2013 Jun;34(23):1708-13, 1713a-1713b [PMID: 23425521]
  81. J Cardiovasc Dev Dis. 2021 Nov 18;8(11): [PMID: 34821711]
  82. BMC Cardiovasc Disord. 2019 Nov 27;19(1):268 [PMID: 31775642]
  83. JACC Cardiovasc Imaging. 2018 Sep;11(9):1301-1310 [PMID: 30190030]
  84. JAMA. 1999 May 26;281(20):1927-36 [PMID: 10349897]
  85. Am J Cardiovasc Dis. 2021 Jun 15;11(3):273-282 [PMID: 34322298]
  86. JAMA Cardiol. 2020 Feb 1;5(2):193-201 [PMID: 31738382]
  87. BMC Cardiovasc Disord. 2019 Apr 8;19(1):88 [PMID: 30961530]
  88. Drugs. 2017 Mar;77(3):265-284 [PMID: 28120185]
  89. Aging Ment Health. 2022 Apr;26(4):762-774 [PMID: 33764244]
  90. J Clin Hypertens (Greenwich). 2020 Jul;22(7):1253-1262 [PMID: 32644257]
  91. Circulation. 2008 Jul 29;118(5):586-606 [PMID: 18586979]
  92. Eur Heart J. 2018 Jan 14;39(3):213-260 [PMID: 28886622]
  93. Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005079 [PMID: 30773025]
  94. J Med Internet Res. 2021 Feb 8;23(2):e18773 [PMID: 33555259]
  95. Am Heart J. 1987 Mar;113(3):645-54 [PMID: 3493674]
  96. Cochrane Database Syst Rev. 2017 Feb 08;2:CD011747 [PMID: 28178363]
  97. J Cardiovasc Comput Tomogr. 2021 Jan-Feb;15(1):16-26 [PMID: 33248903]
  98. J Saudi Heart Assoc. 2015 Jul;27(3):152-9 [PMID: 26136629]
  99. Int J Emerg Med. 2008 Jun;1(2):91-5 [PMID: 19384658]
  100. JACC Cardiovasc Imaging. 2009 Jun;2(6):675-88 [PMID: 19520336]
  101. Cardiovasc Revasc Med. 2018 Dec;19(8):971-975 [PMID: 30056022]
  102. JAMA. 2015 Nov 10;314(18):1955-65 [PMID: 26547467]
  103. Open Cardiovasc Med J. 2018 Apr 23;12:41-49 [PMID: 29755600]
  104. Mayo Clin Proc. 2014 Oct;89(10):1368-77 [PMID: 25199859]
  105. Eur Radiol. 2021 Mar;31(3):1471-1481 [PMID: 32902743]
  106. Circulation. 2021 Nov 9;144(19):1528-1538 [PMID: 34601948]
  107. J Am Heart Assoc. 2019 Sep 3;8(17):e012307 [PMID: 31431112]
  108. Atherosclerosis. 2016 Mar;246:221-8 [PMID: 26803431]
  109. J Clin Med. 2020 Jul 04;9(7): [PMID: 32635532]
  110. Medwave. 2018 Nov 12;18(7):e7332 [PMID: 30451816]
  111. J Am Coll Cardiol. 2006 Oct 3;48(7):1475-97 [PMID: 17010819]
  112. Circulation. 2021 Nov 2;144(18):1476-1484 [PMID: 34459211]
  113. Mayo Clin Proc Innov Qual Outcomes. 2021 Jul 24;5(4):727-741 [PMID: 34355130]
  114. Mil Med. 2017 Nov;182(11):e1973-e1980 [PMID: 29087867]
  115. J Am Coll Cardiol. 2015 Oct 27;66(17):1918-33 [PMID: 26493665]
  116. N Engl J Med. 2018 Jun 21;378(25):e34 [PMID: 29897866]
  117. BMJ. 2017 Jan 19;356:j4 [PMID: 28104622]
  118. N Engl J Med. 2012 Jan 5;366(1):9-19 [PMID: 22077192]
  119. J Am Heart Assoc. 2017 Oct 31;6(11): [PMID: 29089344]
  120. N Engl J Med. 2020 Apr 9;382(15):1395-1407 [PMID: 32227755]
  121. J Cardiovasc Pharmacol. 2020 Mar;75(3):222-228 [PMID: 31876797]
  122. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):261-91 [PMID: 15129710]
  123. Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1198-1207 [PMID: 30982851]
  124. J Am Coll Cardiol. 2005 Oct 18;46(8):1606-13 [PMID: 16226195]
  125. J Am Coll Cardiol. 2005 Jul 5;46(1):147-54 [PMID: 15992649]
  126. Lancet Planet Health. 2020 May;4(5):e195-e208 [PMID: 32442495]
  127. Eur J Prev Cardiol. 2013 Jun;20(3):486-95 [PMID: 21968571]
  128. N Engl J Med. 2007 Apr 12;356(15):1503-16 [PMID: 17387127]
  129. SAGE Open Med. 2020 Nov 20;8:2050312120973493 [PMID: 33282297]
  130. J Am Coll Cardiol. 2003 Oct 1;42(7):1318-33 [PMID: 14522503]
  131. Int J Cardiol. 2015 Dec 15;201:200-7 [PMID: 26298381]
  132. Eur J Prev Cardiol. 2015 Aug;22(8):959-71 [PMID: 25488550]
  133. N Engl J Med. 2010 Mar 11;362(10):886-95 [PMID: 20220183]
  134. Front Psychol. 2021 Oct 20;12:732795 [PMID: 34744903]
  135. Cochrane Database Syst Rev. 2015 May 05;(5):CD005050 [PMID: 25940444]
  136. Circ J. 2010 Apr;74(4):709-14 [PMID: 20208382]
  137. Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):200-206 [PMID: 31218354]
  138. J Saudi Heart Assoc. 2017 Oct;29(4):235-243 [PMID: 28983166]
  139. PLoS One. 2020 Aug 26;15(8):e0238215 [PMID: 32845926]
  140. Am Heart J. 2006 Feb;151(2):404-11 [PMID: 16442907]
  141. Clin Res Cardiol. 2019 May;108(5):487-509 [PMID: 30302558]
  142. BMJ Open. 2017 Feb 23;7(2):e012680 [PMID: 28235965]
  143. JAMA Intern Med. 2016 Jul 1;176(7):1029-32 [PMID: 27295579]
  144. Am Heart J. 1992 Apr;123(4 Pt 1):904-8 [PMID: 1549998]
  145. Eur Heart J Cardiovasc Imaging. 2017 Nov 1;18(11):1191-1204 [PMID: 28329307]
  146. Eur J Prev Cardiol. 2020 Mar;27(4):426-436 [PMID: 31558054]
  147. J Am Coll Cardiol. 2010 Mar 16;55(11):1067-75 [PMID: 20079596]
  148. Eur J Prev Cardiol. 2015 Aug;22(8):1009-17 [PMID: 25082954]
  149. Drugs. 2021 Nov;81(17):2003-2016 [PMID: 34731462]
  150. Saudi Med J. 2004 Sep;25(9):1165-71 [PMID: 15448760]
  151. Int J Cardiol. 2021 Feb 1;324:13-21 [PMID: 33068645]
  152. Korean Circ J. 2020 Sep;50(9):773-786 [PMID: 32725985]
  153. Clin Imaging. 2002 Mar-Apr;26(2):106-11 [PMID: 11852217]
  154. J Nucl Cardiol. 2006 Jan-Feb;13(1):24-33 [PMID: 16464714]
  155. BMC Cardiovasc Disord. 2018 Aug 29;18(1):176 [PMID: 30157753]
  156. Eur Heart J. 2013 Oct;34(38):2949-3003 [PMID: 23996286]
  157. Eur Heart J. 2020 Jan 14;41(3):407-477 [PMID: 31504439]
  158. N Engl J Med. 2019 Feb 14;380(7):629-637 [PMID: 30699054]
  159. Int J Cardiol. 2014 Dec 20;177(3):780-5 [PMID: 25466565]
  160. J Saudi Heart Assoc. 2010 Apr;22(2):47-53 [PMID: 23960594]
  161. Clin Cardiol. 2021 May;44(5):675-682 [PMID: 33742721]
  162. N Engl J Med. 1979 Jun 14;300(24):1350-8 [PMID: 440357]
  163. Heart Views. 2023 Apr-Jun;24(2):67-92 [PMID: 37305331]
  164. Ann Saudi Med. 2014 Nov-Dec;34(6):488-93 [PMID: 25971821]
  165. N Engl J Med. 2009 Mar 5;360(10):961-72 [PMID: 19228612]
  166. J Am Coll Cardiol. 2017 Mar 7;69(9):1172-1187 [PMID: 28254181]
  167. Cochrane Database Syst Rev. 2021 Nov 6;11:CD001800 [PMID: 34741536]
  168. JACC Cardiovasc Interv. 2008 Oct;1(5):483-91 [PMID: 19463349]
  169. Lancet. 2020 Sep 19;396(10254):830-838 [PMID: 32877651]
  170. Cochrane Database Syst Rev. 2021 Apr 29;4:CD010216 [PMID: 33913154]
  171. J Clin Med. 2021 Apr 07;10(8): [PMID: 33916917]
  172. J Am Soc Echocardiogr. 2007 Sep;20(9):1021-41 [PMID: 17765820]
  173. Circulation. 2011 Nov 29;124(22):2423-32, 1-8 [PMID: 22025600]
  174. Eur Heart J. 2021 Apr 7;42(14):1401-1411 [PMID: 33180904]
  175. Eur J Prev Cardiol. 2022 May 25;29(7):1074-1080 [PMID: 34788451]
  176. J Am Heart Assoc. 2021 Mar 16;10(6):e019636 [PMID: 33719496]
  177. N Engl J Med. 2022 Apr 28;386(17):1591-1602 [PMID: 35240010]
  178. Egypt Heart J. 2021 Jan 7;73(1):4 [PMID: 33411160]
  179. J Nucl Med. 2005 Jul;46(7):1095-101 [PMID: 16000277]
  180. Int J Cardiol. 2011 Jan 7;146(1):4-12 [PMID: 20557963]
  181. Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):574-581 [PMID: 30520944]
  182. Eur J Prev Cardiol. 2018 Feb;25(3):247-259 [PMID: 29212370]
  183. Int J Cardiol. 2017 May 15;235:94-99 [PMID: 28284505]
  184. N Engl J Med. 2015 May 7;372(19):1791-800 [PMID: 25773268]
  185. Eur Heart J. 2017 Apr 1;38(13):991-998 [PMID: 27141095]
  186. Eur Heart J. 2020 Jan 14;41(3):347-356 [PMID: 31504434]
  187. J Am Coll Cardiol. 1998 Jan;31(1):144-9 [PMID: 9426033]
  188. Lancet. 2004 Sep 11-17;364(9438):937-52 [PMID: 15364185]
  189. J Am Coll Cardiol. 2019 Feb 5;73(4):400-411 [PMID: 30704571]
  190. J Am Coll Cardiol. 2017 Oct 3;70(14):1689-1700 [PMID: 28958324]
  191. Cochrane Database Syst Rev. 2020 Oct 20;10:CD011748 [PMID: 33078867]
  192. Clin Ther. 2021 Jul;43(7):e217-e229 [PMID: 34092409]
  193. Eur J Clin Pharmacol. 1992;42(3):341-2 [PMID: 1577055]
  194. Front Public Health. 2021 Oct 04;9:658243 [PMID: 34671586]
  195. J Am Coll Cardiol. 2008 Oct 14;52(16):1335-43 [PMID: 18929245]
  196. Int J Cardiol. 2021 Jan 15;323:285-287 [PMID: 32889019]
  197. Int J Gen Med. 2019 Jan 11;12:63-70 [PMID: 30666149]
  198. J Am Soc Echocardiogr. 2008 Nov;21(11):1179-201; quiz 1281 [PMID: 18992671]
  199. J Am Coll Cardiol. 2005 Jul 5;46(1):158-65 [PMID: 15992651]
  200. Cochrane Database Syst Rev. 2019 Mar 13;3:CD009825 [PMID: 30864165]
  201. J Am Coll Cardiol. 2005 Aug 2;46(3):552-7 [PMID: 16053973]
  202. J Am Coll Cardiol. 2006 Sep 5;48(5):1029-39 [PMID: 16949498]
  203. N Engl J Med. 2015 Apr 2;372(14):1291-300 [PMID: 25773919]
  204. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021 [PMID: 33309175]
  205. Circulation. 1997 Jul 1;96(1):345-54 [PMID: 9236456]
  206. J Am Coll Cardiol. 2020 Nov 24;76(21):2421-2432 [PMID: 33213720]
  207. Iran J Public Health. 2015 Feb;44(2):170-5 [PMID: 25905050]
  208. BMC Cardiovasc Disord. 2017 Apr 28;17(1):105 [PMID: 28454527]
  209. BMJ. 2018 Feb 21;360:k504 [PMID: 29467161]
  210. Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):1-7 [PMID: 33165600]
  211. Ann Intern Med. 1987 Jun;106(6):793-800 [PMID: 3579066]
  212. Cureus. 2020 Nov 30;12(11):e11791 [PMID: 33282602]
  213. JAMA Cardiol. 2018 Apr 1;3(4):280-287 [PMID: 29490333]
  214. Arch Intern Med. 2008 Nov 10;168(20):2194-204 [PMID: 19001195]
  215. J Saudi Heart Assoc. 2020 Jun 04;32(2):236-241 [PMID: 33154923]
  216. Mediators Inflamm. 2021 Sep 04;2021:9661752 [PMID: 34526854]
Journal Article
Article has an altmetric score of 7

Word Cloud

Created with Highcharts 10.0.0SaudiCCSArabiamanagementclinicalmedicallocalHeartevidenceconsideringcoronarysyndromepatientsguidelinesConsensusexpertsAssociationreviewedcharacteristicspopulationhealthcareensuretherapypharmacologicalappropriatenecessaryGuidelinesChronicBackground:prevalencechronicriskfactorsalarmingminorityachieveoptimalContext-specificoutliningbestpracticesthereforeneededaddressgapschallengespanel:panelrepresentingSHAexistingformulatedguidancerelevantpracticesystemresourcesexpertiseexternalscientificaccuracyfindings:RecommendationsprovidedassessmentalongsupportingRiskreductionnon-pharmacologicallifestylemodificationsremainscoreGreatemphasisplaceduseavailableoptionsanti-anginaleventpreventionLifestylecounselingstrategymustoptimizedrevascularizationunlessotherwiseindicatedRevascularizationstrategiescarefullyconsideredTeamchoicemadeaccordancecurrentpatientpreferenceConclusion:ConscientiousmultidisciplinarypersonalizednavigatecomplexlandscaperesourcedifferencesreconciliationinternationalcriticalimprovementoutcomesamongBestPracticesManagementCoronarySyndromes

Similar Articles

Cited By